CDC Statement on Marburg Cases in Rwanda
CDC Bolsters Rwanda’s Health Security Amidst Marburg Virus Disease Outbreak
The U.S. Centers for disease Control and Prevention (CDC) is actively supporting Rwanda’s efforts to combat the Marburg virus disease outbreak, leveraging a long-standing partnership and extensive experience in global health security. with an established office in Rwanda as 2002, the CDC has been a dedicated collaborator with the Rwandan government, focusing on strengthening health systems and preventing communicable diseases.
A Deep-Rooted Partnership for Public Health
The CDC’s presence in Rwanda is marked by a robust collaboration aimed at enhancing the nation’s capacity to address critical public health challenges. This partnership has been instrumental in various health initiatives, including:
Field Epidemiology Training Program (FETP): The CDC actively trains scientists through the FETP, significantly bolstering Rwanda’s ability to investigate and respond to disease outbreaks effectively. This program builds essential local expertise for disease surveillance and management. President’s Emergency Plan for AIDS Relief (PEPFAR): CDC has worked closely with the Republic of Rwanda to implement PEPFAR, a vital initiative that has made critically important strides in combating the HIV/AIDS epidemic.
President’s Malaria Initiative (PMI): Co-implemented with USAID, the PMI has been crucial in reducing the burden of malaria in rwanda, demonstrating a commitment to tackling major infectious diseases.
These sustained investments and collaborative efforts have fortified Rwanda’s core public health capabilities, providing a strong foundation for responding to the current Marburg virus disease outbreak. The CDC’s ongoing coordination extends across the U.S. Government, including close collaboration with the U.S. Ambassador to Rwanda and the team on the ground, to address pressing health concerns. Moreover,the CDC maintains a trusted and enduring relationship with the Ministry of Health in Rwanda,fostering open communication and joint action.
Enhanced Support for Outbreak Response
In response to the Marburg virus disease outbreak, the CDC has mobilized additional resources and expertise to support Rwanda. This includes the deployment of subject matter experts who will provide critical assistance with the country’s investigation and response activities.
Specialized Expertise Deployed
The CDC staff arriving in rwanda bring invaluable experience from responding to Marburg virus disease and similar viral hemorrhagic fevers in other countries. Their specialized skills will be applied to several key areas:
Epidemiology: Providing in-depth analysis of disease patterns, transmission, and risk factors.
Contact Tracing: Identifying and monitoring individuals who may have been exposed to the virus.
Laboratory testing: Supporting diagnostic capabilities to accurately detect and confirm cases.
disease Detection and Control: Implementing strategies to prevent the spread of the virus, particularly along borders.
Hospital Infection Prevention and Control: Ensuring that healthcare facilities are equipped to safely manage patients and protect healthcare workers.
Understanding Marburg Virus Disease
Marburg virus disease is a rare but severe viral hemorrhagic fever, sharing similarities with Ebola. It is indeed known to be spread in several African countries by certain types of bats and can cause deadly infections in humans.
Transmission and Risk Factors
The virus can transmit from person to person through direct contact with the bodily fluids of infected individuals, such as blood, secretions, and organs. Healthcare workers in outbreak settings are at a heightened risk of infection due to close contact with patients.
Symptoms of Marburg Virus Disease
Symptoms of Marburg virus disease typically appear suddenly and can include:
Fever
Rash
* Severe bleeding
For more extensive facts on Marburg virus disease, please visit the CDC’s dedicated resource on the topic.